Pharma Pulse: ACOG Reaffirms COVID-19 Vaccine in Pregnancy, SGLT2 Real-World Safety Data, and EVERSANA–Waltz Tackle Drug Costs

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering updates in maternal health guidance, real-world diabetes data, and a new partnership aimed at lowering drug costs and improving access.

• The American College of Obstetricians and Gynecologists (ACOG) has reaffirmed its support for COVID-19 vaccination during pregnancy, even as it distances itself from recent CDC guidance. ACOG emphasized that vaccination remains safe and effective for protecting both pregnant individuals and their newborns from severe illness. The statement underscores ongoing efforts to ensure maternal populations remain a focus in vaccine policy, especially as hesitancy persists in some communities.
• In other news, new real-world evidence shows that the SGLT2 inhibitors dapagliflozin and empagliflozin are safe and effective for patients with type 2 diabetes. The study found no new safety concerns, reinforcing their role in improving both glycemic control and cardiovascular outcomes. With diabetes prevalence continuing to rise globally, the findings strengthen confidence in SGLT2 therapies as a key option in managing long-term complications.
• Lastly, in market access news, EVERSANA and Waltz Health are joining forces to launch a platform designed to tackle drug costs and improve patient access. The system leverages data, analytics, and real-time pricing to help patients and providers identify the most affordable options at the point of care. By combining EVERSANA’s commercialization expertise with Waltz’s technology, the collaboration aims to improve transparency and reduce out-of-pocket burdens for patients navigating an increasingly complex drug pricing landscape.

From maternal health guidance to real-world diabetes safety data and innovative pricing platforms, these stories highlight how science, practice, and technology are working together to improve patient care.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.